Hem › Blåscancer › Illinois › Chicago
Kliniska studier för Blåscancer i Chicago, IL
21 studier för Blåscancer söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekryterarFas 1
- University of Chicago Hospital, Chicago
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RekryterarFas 1/2
- University of Chicago Medical Center ( Site 5037), Chicago
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekryterarFas 3
- Northwestern University, Chicago
- University of Illinois, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- och 1 fler
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RekryterarFas 2
- Rush MD Anderson Cancer Center, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 2
- University of Illinois Cancer Center, Chicago
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekryterarFas 2
- Northwestern University, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekryterarFas 2
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RekryterarFas 1
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekryterarFas 3
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekryterarFas 1
- The University of Chicago Medical Center (UCMC), Chicago
Measuring Surgical Recovery After Radical Cystectomy
RekryterarObservationsstudie
- University of Chicago, Chicago
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekryterarFas 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekryterarFas 2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekryterarFas 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
RekryterarFas 2
- Northwestern University, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekryterarFas 1
- The University of Chicago Comprehensive Cancer Center, Chicago
Blue Light Cystoscopy With Cysview® Registry
RekryterarObservationsstudie
- Northwestern University, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Chicago
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
RekryterarObservationsstudie
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
Rekryterar
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Blåscancer-studier i andra städer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer58 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Övervikt41 studier
- Lungcancer41 studier
- Äggstockscancer36 studier
- Stroke34 studier
- Kolorektal cancer33 studier
- Hjärtsvikt31 studier
- Övervikt28 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.